Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer gipam mercoledì, febbraio 14, 2018 Social Media , Social Media 2018 Edit Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer https://www.ncbi.nlm.nih.gov/pubmed/29227724 Share on Facebook Share on Twitter Share on Google Plus RELATED POSTS HER2 amplification is a distinct dr...Social Mediail problema di una equivoca amplifi...
0 commenti:
Posta un commento